These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17996696)

  • 21. Immunoglobulin fragment F(ab')
    Pan X; Zhou P; Fan T; Wu Y; Zhang J; Shi X; Shang W; Fang L; Jiang X; Shi J; Sun Y; Zhao S; Gong R; Chen Z; Xiao G
    Antiviral Res; 2020 Oct; 182():104868. PubMed ID: 32659292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
    Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
    Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine immunoglobulin F(ab')
    Zhao Y; Zheng X; He S; Li Y; Wang W; Gai W; Wong G; Wang H; Yan F; Xue F; Feng N; Wang T; Gao Y; Yang S; Qiu X; Xia X
    Int Immunopharmacol; 2018 Nov; 64():217-222. PubMed ID: 30199846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection.
    Cui J; Zhao Y; Wang H; Qiu B; Cao Z; Li Q; Zhang Y; Yan F; Jin H; Wang T; Sun W; Feng N; Gao Y; Sun J; Wang Y; Perlman S; Zhao J; Yang S; Xia X
    Viruses; 2016 Dec; 8(12):. PubMed ID: 27999340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.
    Yu JR; Lennette ET; Karpatkin S
    J Clin Invest; 1986 Jun; 77(6):1756-61. PubMed ID: 3011860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-immunoglobulin responses to IgG, F(ab')2, and Fab botulinum antitoxins in mice.
    Mayers CN; Veall S; Bedford RJ; Holley JL
    Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):397-408. PubMed ID: 19180802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.
    Hammoudi-Triki D; Lefort J; Rougeot C; Robbe-Vincent A; Bon C; Laraba-Djebari F; Choumet V
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):205-14. PubMed ID: 17198719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-rabies immunoglobulin preparation based on F(ab')2 fragments].
    Nikiforov AK; Volokh OA; Lobovikova OA; Diatlov IA; Zhulidov IM
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (1):72-4. PubMed ID: 17523436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
    Chapoval AI; Nelson H; Thibault C
    J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity targeting of Sendai virions to desialized human erythrocytes using hybrid antibody molecules.
    Chejanovsky N; Fridlender B; Loyter A
    Biochim Biophys Acta; 1985 Jan; 812(2):353-60. PubMed ID: 2981547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.
    Kam YW; Kien F; Roberts A; Cheung YC; Lamirande EW; Vogel L; Chu SL; Tse J; Guarner J; Zaki SR; Subbarao K; Peiris M; Nal B; Altmeyer R
    Vaccine; 2007 Jan; 25(4):729-40. PubMed ID: 17049691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
    Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
    J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.
    Racine T; Denizot M; Pannetier D; Nguyen L; Pasquier A; Raoul H; Saluzzo JF; Kobinger G; Veas F; Herbreteau CH
    J Infect Dis; 2019 Jun; 220(1):41-45. PubMed ID: 30852585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-SARS-CoV-2 equine F (Ab')
    Botosso VF; Jorge SAC; Astray RM; de Sá Guimarães AM; Mathor MB; de Carneiro PDS; Durigon EL; Covas D; de Oliveira DBL; das Neves Oliveira R; Maria DA; Eto SF; Gallina NMF; Pidde G; Squaiella-Baptistão CC; Silva DT; Villas-Boas IM; Fernandes DC; Auada AVV; Banari AC; de Souza Filho AF; Bianconi C; de Agostini Utescher CL; Oliveira DCA; Mariano DOC; Barbosa FF; Rondon G; Kapronezai J; da Silva JG; Goldfeder MB; Comone P; Junior REC; Pereira TTS; Wen FH; Tambourgi DV; Chudzinski-Tavassi AM
    Sci Rep; 2022 Mar; 12(1):3890. PubMed ID: 35273234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
    Li D; Luan N; Li J; Zhao H; Zhang Y; Long R; Jiang G; Fan S; Xu X; Cao H; Wang Y; Liao Y; Wang L; Liu L; Liu C; Li Q
    Emerg Microbes Infect; 2021 Dec; 10(1):2194-2198. PubMed ID: 34736354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.